The Japan presidents of foreign pharma companies are no longer hiding their concerns about the stagnation of drug development in the Japanese market. In their business briefings for 2021, many of them made explicit criticism against what they see as…
HOME > TOP STORIES
TOP STORIES
-
ORGANIZATION Maker FTC Bans Drink Donations at Academic Conferences
September 19, 2012
-
BUSINESS Chugai Provides All-Case PMS Data via iPad, Beginning with Avastin
September 18, 2012
-
BUSINESS JT Sees Silver Lining in Pharmaceutical Biz 25 Yrs after Market Entry; 1st Approval Obtained for Proprietary Drug
September 14, 2012
-
REGULATORY Osaka District Court to Issue Ruling on Actos Patent Suit on Sept. 27
September 12, 2012
-
BUSINESS Wholesalers Unlikely to See Significant Progress in Price Negotiations By End of September
September 12, 2012
-
BUSINESS Pharmaceutical Companies Beefing Up Training for Cancer Specialized MRs
September 11, 2012
-
BUSINESS DSP Revising Midterm Business Plan – Will It Be Able to Hammer Out Effective Measures against Stagnant Domestic Business?
September 10, 2012
-
BUSINESS Kissei Aims for 40% Market Share for Epoetin Alfa at Early Stage
September 7, 2012
-
BUSINESS Nippon Shinyaku Plans Generic Launch to Complement Its New Drug Lineup in Priority Field
September 6, 2012
-
BUSINESS Meiji Seika Pharma Aims to Bolster Presence with COPD Drug Oxis
September 5, 2012
-
BUSINESS RaQualia to Focus on Fields Where It Can Exhibit Uniqueness, Compile Biz Strategy in November
September 4, 2012
-
BUSINESS DSP’s US Subsidiary Sunovion to Acquire Elevation Pharmaceuticals of the US
September 3, 2012
-
REGULATORY MHLW to Seek Funds to Enhance Regulatory Consultation under FY2013 “Priority Budget Scheme”
September 3, 2012
-
BUSINESS Sosei Committed to Becoming a Japan-Based Global Biopharma: Vice President Akihiro Matsuura
September 3, 2012
-
BUSINESS Ribomic Aims to Commercialize Non-Addictive Analgesic Nucleic Acid Drug
August 30, 2012
-
REGULATORY MHLW to Include Creation of Drug Discovery Support Network in FY2013 Draft Budget Request
August 30, 2012
-
BUSINESS Takeda Gearing Up for Emerging Market Operations
August 29, 2012
-
REGULATORY PMDA Eyes World’s First Approval for New Drugs: Chief Executive Kondo
August 28, 2012
-
BUSINESS Large Portfolio, Competitive Prices, High Quality to Be Key to Success in Generics Business: Mr Bourla of Pfizer
August 27, 2012
-
BUSINESS Kyowa Kirin, Otsuka Still Working Out Specifics for Cooperation in Field of Oncology
August 27, 2012
ページ
The missing ingredient for managers is not their skill, ability, or education. Academic achievements and business success will get runs on the board, to a certain level. However, that is just half of the story.Leaders come in all shapes and…
The average ratio of females in managerial posts at Japanese drug makers has finally reached a double-digit number, at 10.0%, a Jiho survey found. However, this is still well below a near-25% ratio logged by foreign players operating in the…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…
A total of 15 new drugs (APIs) joined the NHI price list in 2021 with peak sales forecasts topping at 10 billion yen, many of them in the area of orphan diseases and with few mega launches, according to a…